# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Epstein Barr Virus, Chronic

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 116 results.
Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
Status: Completed
Last Changed: Jun 28, 2017
First Received: Jan 09, 2015
Disease(s): Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections
Locations: Dept. of Pediatrics, Akershus University Hospital, Lørenskog, Akershus, Norway
Genetic Studies of Chronic Active Epstein-Barr Disease
Status: Recruiting
Last Changed: Apr 02, 2020
First Received: Mar 25, 2002
Disease(s): Chronic Active Epstein-Barr Virus
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome
Status: Completed
Last Changed: Mar 19, 2009
First Received: Feb 09, 2007
Disease(s): Chronic Fatigue Syndrome
Locations: University of Mississippi Medical Center, Jackson, Mississippi, United States
Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
Status: Unknown status
Last Changed: Aug 31, 2007
First Received: May 24, 2007
Disease(s): Chronic Fatigue Syndrome
Intervention(s): valganciclovir
Locations: Stanford University Medical Center, Stanford, California, United States
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
Status: Completed
Last Changed: Jan 18, 2020
First Received: Apr 09, 2003
Disease(s): Epstein-Barr Virus Infections
Intervention(s): Intravenous injection of EBV specific CTLS
Locations: Texas Children's Hospital, Houston, Texas, United States
The Methodist Hospital, Houston, Texas, United States
Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial
Status: Recruiting
Last Changed: May 21, 2019
First Received: Oct 09, 2018
Disease(s): COPD, EBV
Intervention(s): Valaciclovir, Placebo capsules (containing Avicel blend)
Locations: Belfast Health and Social Care Trust, Belfast, Down, United Kingdom
Mental Training for CFS Following EBV Infection in Adolescents
Status: Unknown status
Last Changed: Jan 10, 2018
First Received: Jul 16, 2015
Disease(s): Fatigue Syndrome, Chronic, Epstein-Barr Virus Infection
Intervention(s): Mental training
Locations: Dept. of Pediatrics, Akershus University Hospital, Lørenskog, Akershus, Norway
Chronic Presence of Epstein Barr Virus in Epithelial Cells From Gingiva is Associated With Periodontitis
Status: Unknown status
Last Changed: Dec 18, 2012
First Received: Nov 23, 2010
Disease(s): Chronic Periodontitis, Aggressive Periodontitis, Presence / Absence of EBV
Intervention(s): dental root planing, dental root planing, dental root planing
Locations: Dr Severine VINCENT, Nice, France
Chronic Presence of Epstein Barr Virus in Sulcular and Junctional Epithelial Tissue From Gingiva is Associated With Severe Periodontitis
Status: Unknown status
Last Changed: Aug 07, 2012
First Received: Nov 23, 2010
Disease(s): Parodontitis Aggressive, Parodontitis Chronic
Intervention(s): Biopsy, biopsy, Biopsy
Locations: CHU de Nice, Hôpital Saint Roch, Nice, France
PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
Status: Recruiting
Last Changed: Feb 11, 2020
First Received: Sep 10, 2019
Disease(s): EBV Infection
Intervention(s): PD1 antibody, lenalidomide
Locations: Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China